☰

Joseph D. Tellez, Ph.D. - Publications

Affiliations: 
2009 Cell and Molecular Biology University of Nevada, Reno, Reno, NV, United States 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, Swamynathan M, Chen M, Murphy W, Carraway K, Sweeney C. Abstract LB-021: LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of triple-negative/basal-B breast cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-021  0.319
2015 Yokdang N, Hatakeyama J, Wald JH, Simion C, Tellez JD, Chang DZ, Swamynathan MM, Chen M, Murphy WJ, Carraway Iii KL, Sweeney C. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. PMID 26387542 DOI: 10.1038/Onc.2015.345  0.333
2014 Tellez J, Jaing C, Wang J, Green R, Chen M. Detection of Epstein-Barr virus (EBV) in human lymphoma tissue by a novel microbial detection array. Biomarker Research. 2: 24. PMID 25635226 DOI: 10.1186/S40364-014-0024-X  0.345
2014 Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. Bmc Cancer. 14: 756. PMID 25301268 DOI: 10.1186/1471-2407-14-756  0.317
2014 Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 124: 1677-88. PMID 25009225 DOI: 10.1182/Blood-2014-02-554279  0.359
2014 Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Tellez J, Monjazeb AM, Murphy WJ. Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma Cancer Research. 74: 1929-1929. DOI: 10.1158/1538-7445.Am2014-1929  0.409
2013 Tellez J, Van Vliet K, Tseng YS, Finn JD, Tschernia N, Almeida-Porada G, Arruda VR, Agbandje-McKenna M, Porada CD. Characterization of naturally-occurring humoral immunity to AAV in sheep. Plos One. 8: e75142. PMID 24086458 DOI: 10.1371/Journal.Pone.0075142  0.583
2013 Canter RJ, Ames E, Tellez J, Smith RC, Murphy WJ. Abstract 4894: Sorafenib enriches for sarcoma cancer stem cellsin vitro. Cancer Research. 73: 4894-4894. DOI: 10.1158/1538-7445.Am2013-4894  0.332
2012 Ozturk F, Park PJ, Tellez J, Colletti E, Eiden MV, Almeida-Porada G, Porada CD. Expression levels of the PiT-2 receptor explain, in part, the gestational age-dependent alterations in transduction efficiency after in utero retroviral-mediated gene transfer. The Journal of Gene Medicine. 14: 169-81. PMID 22262359 DOI: 10.1002/Jgm.2607  0.703
2011 Yokdang N, Tellez JD, Tian H, Norvell J, Barsky SH, Valencik M, Buxton ILO. A role for nucleotides in support of breast cancer angiogenesis: Heterologous receptor signalling British Journal of Cancer. 104: 1628-1640. PMID 21505453 DOI: 10.1038/Bjc.2011.134  0.325
2011 Xiao Y, Ye Y, Zou X, Jones S, Yearsley K, Shetuni B, Tellez J, Barsky SH. The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction Oncogene. 30: 287-300. PMID 20838375 DOI: 10.1038/Onc.2010.405  0.414
2011 Barsky SH, Ye Y, Tellez JD, Belcher M. Abstract 5232: Lymphovascular breast carcinoma tumoral emboli beget emboli through stem-cell initiated self-budding histogenesis Cancer Research. 71: 5232-5232. DOI: 10.1158/1538-7445.Am2011-5232  0.342
2010 Tellez J, Finn JD, Tschernia N, Almeida-Porada G, Arruda V, Porada CD. Naturally-Occurring Antibodies to Human AAV In Sheep: A New Large Animal Model for Immune Aspects of AAV Gene Transfer. Blood. 116: 3762-3762. DOI: 10.1182/Blood.V116.21.3762.3762  0.613
2009 Park PJ, Colletti E, Ozturk F, Wood JA, Tellez J, Almeida-Porada G, Porada C. Factors determining the risk of inadvertent retroviral transduction of male germ cells after in utero gene transfer in sheep. Human Gene Therapy. 20: 201-15. PMID 19301473 DOI: 10.1089/Hum.2007.120  0.701
2005 Porada CD, Park PJ, Tellez J, Ozturk F, Glimp HA, Almeida-Porada G, Zanjani ED. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 754-62. PMID 16084775 DOI: 10.1016/J.Ymthe.2005.05.011  0.699
2005 Ozturk F, Park P, Tellez J, Anderson WB, Eiden M, Zanjani ED, Almeida-Porada G, Porada CD. 750. Expression Levels of the Amphotropic Receptor May Explain Gestational Age-Dependence of Tissue Transduction in Fetal Sheep Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.290  0.699
2004 Park PJ, Tellez J, Almeida-Porada G, Zanjani ED, Porada CD. 1052. Male Germline Cells Appear To Be at Risk Following Direct Injection Gene Transfer In Utero Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.997  0.693
Show low-probability matches.